ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN was delisted on the 18th of July, 2024.
12 hedge funds and large institutions have $8.25M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
71% more funds holding
Funds holding: 7 → 12 (+5)
27% more capital invested
Capital invested by funds: $6.48M → $8.25M (+$1.77M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.68M |
| 2 |
Temasek Holdings
Singapore
|
+$469K |
| 3 |
Renaissance Technologies
New York
|
+$453K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$388K |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$161K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$164K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Temasek Holdings
Singapore
| $3.07M | +$469K | +6,390 | +18% |
|
|
SCM
2
Sio Capital Management
New York
| $2.55M | +$28.8K | +392 | +1% |
|
|
PIM
3
Platinum Investment Management
Sydney Australia 2000,
Australia
| $942K | +$161K | +2,196 | +21% |
|
|
4
Renaissance Technologies
New York
| $595K | +$453K | +6,175 | +317% |
|
|
IC
5
Ikarian Capital
Dallas,
Texas
| $405K | +$3.68M | +50,161 | New |
|
|
BFM
6
Boothbay Fund Management
New York
| $387K | +$388K | +5,287 | New |
|
7
Morgan Stanley
New York
| $148K | +$146K | +1,985 | +4,223% |
|
8
Citadel Advisors
Miami,
Florida
| $66K | +$66K | +899 | New |
|
9
State Street
Boston,
Massachusetts
| $52K | +$52.1K | +710 | New |
|
|
VF
10
Virtu Financial
New York
| $26K | +$25.5K | +347 | New |
|
|
AF
11
Allworth Financial
Folsom,
California
| $3K | +$2.79K | +38 | New |
|
12
UBS Group
Zurich,
Switzerland
| $2K | +$2.28K | +31 | New |
|
|
DCM
13
DAFNA Capital Management
Los Angeles,
California
| – | -$164K | -2,152 | Closed |
|
|
14
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$31K | -408 | Closed |
|
ASLN Hedge Fund Activity: Q4 2020 in Review
12 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q4 2020, worth a combined $8.25M — up 27% from $6.48M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ASLN positions and 2 closed out — a net gain of 5 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $3.68M. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $164K sold.
- 12 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q4 2020, up from 7 in Q3 2020.
- Funds reported $8.25M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q4 2020, up 27% quarter-over-quarter.
- 7 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q4 2020 and 2 closed out, a net change of +5 holders.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q4 2020 was Ikarian Capital, an estimated $3.68M added.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q4 2020 was DAFNA Capital Management, an estimated $164K sold.
Based on aggregated 13F filings for Q4 2020.